HEALTH SYSTEMS

Article: Shortage of anti-infective drugs needs government attention

Anti-infective drug shortages pose significant problems for clinicians and are a rapidly evolving public-health emergency that may require government oversight, according to an article published online January 19 in Clinical Infectious Diseases. » More

DIABETES MANAGEMENT

ACP recommends metformin as first-line therapy for type 2 diabetes

Physicians should prescribe oral metformin as a first-line therapy for most patients with type 2 diabetes, as well as for those whose blood sugar cannot be controlled with diet, exercise, and weight loss, according to new guidelines from the American College of Physicians. » More

Poorly controlled diabetes may lead to hearing loss in women

Uncontrolled diabetes may result in hearing loss in women, much like it affects vision or kidney function, according to the results of a new study. » More

CONTINUING EDUCATION

Cardiometabolic disease: The pharmacist’s role in managing weight loss and medication adherence

Pharmacists can help with the management of weight loss through nutrition education, exercise counseling, and strategies for medication adherence.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

FDA ACTIONS

FDA, companies working to increase short supply of leukemia drug

FDA and 3 drug manufacturers say they are working to allay the concerns of health organizations that the supply of methotrexate – used to treat acute lymphoblastic leukemia in children – is in danger of running out. » More

FDA issues 3 draft guidances on biosimilars

FDA has issued 3 draft guidances for the development of biosimilar versions of approved biologic products, which will help flesh out the abbreviated approval pathway created by the Patient Protection and Affordable Care Act signed into law in 2010. » More

FDA extends approval for drug to treat adult ADHD

FDA has approved lisdexamfetamine dimesylate (Vyvanse, Shire) capsules, (CII) as a maintenance treatment for adults with ADHD. Vyvanse was already approved as a treatment for ADHD in patients aged 6 to 17 years. » More

CLINICAL NEWS

Study finds association between open-angle glaucoma and ED

Men with ED also were more likely to have had open-angle glaucoma than those without ED, according to a study published in the February 12 online issue of Ophthalmology.
» More

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Drug Topics please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff

Voices

Digital Edition